Daniela Matei

  • 7329 Citations
  • 43 h-Index
19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Filter
Article

Acquired thrombophilic syndromes

Matei, D., Brenner, B. & Marder, V. J., Jan 1 2001, In : Blood Reviews. 15, 1, p. 31-48 18 p.

Research output: Contribution to journalArticle

14 Scopus citations
71 Scopus citations

Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: A Gynecologic Oncology Group trial

Matei, D., Sill, M. W., Lankes, H. A., DeGeest, K., Bristow, R. E., Mutch, D., Yamada, S. D., Cohn, D., Calvert, V., Farley, J., Petricoin, E. F. & Birrer, M. J., Jan 1 2011, In : Journal of Clinical Oncology. 29, 1, p. 69-75 7 p.

Research output: Contribution to journalArticle

137 Scopus citations

Actual 5-year survival of patients with stage IIIB breast carcinoma: Phase II trial of methotrexate, vinblastine, adriamycin, cisplatin, and folinic acid

Madajewicz, S., Matei, D., Hentschel, P., Kudelka, A., Abel, W., Fiore, J. J., DaCosta, N. A. & Pendyala, L., Jan 1 1999, In : Cancer Investigation. 17, 7, p. 463-467 5 p.

Research output: Contribution to journalArticle

6 Scopus citations

Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer

Matei, D., Filiaci, V., Randall, M. E., Mutch, D., Steinhoff, M. M., DiSilvestro, P. A., Moxley, K. M., Kim, Y. M., Powell, M. A., O’Malley, D. M., Spirtos, N. M., Small, W., Tewari, K. S., Richards, W. E., Nakayama, J., Matulonis, U. A., Huang, H. Q. & Miller, D. S., Jun 13 2019, In : New England Journal of Medicine. 380, 24, p. 2317-2326 10 p.

Research output: Contribution to journalArticle

31 Scopus citations

An effective epigenetic-PARP inhibitor combination therapy for breast and ovarian cancers independent of BRCA mutations

Pulliam, N., Fang, F., Ozes, A. R., Tang, J., Adewuyi, A., Keer, H., Lyons, J., Baylin, S. B., Matei, D., Nakshatri, H., Rassool, F. V., Miller, K. D. & Nephew, K. P., Jul 1 2018, In : Clinical Cancer Research. 24, 13, p. 3163-3175 13 p.

Research output: Contribution to journalArticle

21 Scopus citations

An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer

Gordon, M. S., Robert, F., Matei, D., Mendelson, D. S., Goldman, J. W., Chiorean, E. G., Strother, R. M., Seon, B. K., Figg, W. D., Peer, C. J., Alvarez, D., Adams, B. J., Theuer, C. P. & Rosen, L. S., Dec 1 2014, In : Clinical Cancer Research. 20, 23, p. 5918-5926 9 p.

Research output: Contribution to journalArticle

46 Scopus citations

A novel aldh1a1 inhibitor targets cells with stem cell characteristics in ovarian cancer

Nwani, N. G., Condello, S., Wang, Y., Swetzig, W. M., Barber, E., Hurley, T. & Matei, D., Apr 2019, In : Cancers. 11, 4, 502.

Research output: Contribution to journalArticle

Open Access
4 Scopus citations

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer

Fang, F., Balch, C., Schilder, J., Breen, T., Zhang, S., Shen, C., Li, L., Kulesavage, C., Snyder, A. J., Nephew, K. P. & Matei, D. E., Sep 1 2010, In : Cancer. 116, 17, p. 4043-4053 11 p.

Research output: Contribution to journalArticle

105 Scopus citations

A phase i clinical trial of guadecitabine and carboplatin in platinum-resistant, recurrent ovarian cancer: Clinical, pharmacokinetic, and pharmacodynamic analyses

Matei, D., Ghamande, S., Roman, L., Secord, A. A., Nemunaitis, J., Markham, M. J., Nephew, K. P., Jueliger, S., Oganesian, A., Naim, S., Su, X. Y., Keer, H., Azab, M. & Fleming, G. F., May 15 2018, In : Clinical Cancer Research. 24, 10, p. 2285-2293 9 p.

Research output: Contribution to journalArticle

19 Scopus citations

A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinoma

Kimball, K. J., Numnum, T. M., Kirby, T. O., Zamboni, W. C., Estes, J. M., Barnes, M. N., Matei, D. E., Koch, K. M. & Alvarez, R. D., Oct 1 2008, In : Gynecologic oncology. 111, 1, p. 95-101 7 p.

Research output: Contribution to journalArticle

31 Scopus citations

Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer

Goodman, C. R., Hatoum, S., Seagle, B. L. L., Donnelly, E. D., Barber, E. L., Shahabi, S., Matei, D. & Strauss, J. B., Jan 1 2019, (Accepted/In press) In : Gynecologic Oncology.

Research output: Contribution to journalArticle

4 Scopus citations

Autocrine activation of PDGFRα promotes the progression of ovarian cancer

Matei, D., Emerson, R. E., Lai, Y. C., Baldridge, L. A., Rao, J., Yiannoutsos, C. & Donner, D. B., Mar 30 2006, In : Oncogene. 25, 14, p. 2060-2069 10 p.

Research output: Contribution to journalArticle

97 Scopus citations

Biodynamic imaging for phenotypic profiling of three-dimensional tissue culture

Sun, H., Merrill, D., An, R., Turek, J., Matei, D. & Nolte, D. D., Jan 1 2017, In : Journal of Biomedical Optics. 22, 1, 016007.

Research output: Contribution to journalArticle

7 Scopus citations

Breast mass in a patient with ovarian cancer: A case report

Gayathri, S., Badve, S. & Matei, D., Oct 1 2009, In : Journal of Reproductive Medicine for the Obstetrician and Gynecologist. 54, 10, p. 639-644 6 p.

Research output: Contribution to journalArticle

3 Scopus citations
26 Scopus citations

Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: A gynecologic oncology group study

Matei, D., Miller, A. M., Monahan, P., Gershenson, D., Zhao, Q., Cella, D., Champion, V. L. & Williams, S. D., Sep 1 2009, In : Journal of Clinical Oncology. 27, 25, p. 4142-4149 8 p.

Research output: Contribution to journalArticle

32 Scopus citations

Circulating tumor cell detection using a parallel flow micro-aperture chip system

Chang, C. L., Huang, W., Jalal, S. I., Chan, B. D., Mahmood, A., Shahda, S., O'Neil, B. H., Matei, D. E. & Savran, C. A., Apr 7 2015, In : Lab on a Chip. 15, 7, p. 1677-1688 12 p.

Research output: Contribution to journalArticle

53 Scopus citations

Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: Potential predictive relationship with tumor HER2 activation status

Gordon, M. S., Matei, D., Aghajanian, C., Matulonis, U. A., Brewer, M., Fleming, G. F., Hainsworth, J. D., Garcia, A. A., Pegram, M. D., Schilder, R. J., Cohn, D. E., Roman, L., Derynck, M. K., Ng, K., Lyons, B., Allison, D. E., Eberhard, D. A., Pham, T. Q., Dere, R. C. & Karlan, B. Y., Sep 10 2006, In : Journal of Clinical Oncology. 24, 26, p. 4324-4332 9 p.

Research output: Contribution to journalArticle

204 Scopus citations

Concurrent Detection of Cellular and Molecular Cancer Markers Using an Immunomagnetic Flow System

Huang, W., Chang, C. L., Chan, B. D., Jalal, S. I., Matei, D. E., Low, P. S. & Savran, C. A., Jul 12 2015, In : Analytical Chemistry. 87, 20, p. 10205-10212 8 p.

Research output: Contribution to journalArticle

7 Scopus citations

Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer

Hess, L. M., Rong, N., Monahan, P. O., Gupta, P., Thomaskutty, C. & Matei, D., Nov 15 2010, In : Cancer. 116, 22, p. 5251-5260 10 p.

Research output: Contribution to journalArticle

16 Scopus citations

Decitabine reactivated pathways in platinum resistant ovarian cancer

Fang, F., Zuo, Q., Pilrose, J., Wang, Y., Shen, C., Li, M., Wulfridge, P., Matei, D. & Nephew, K. P., 2014, In : Oncotarget. 5, 11, p. 3579-3589 11 p.

Research output: Contribution to journalArticle

Open Access
22 Scopus citations

Endoglin for targeted cancer treatment.

Rosen, L. S., Gordon, M. S., Robert, F. & Matei, D. E., 2014, In : Current Oncology Reports. 16, 2, p. 365 1 p.

Research output: Contribution to journalArticle

Endoglin for targeted cancer treatment topical collection on evolving therapies

Rosen, L. S., Gordon, M. S., Robert, F. & Matei, D. E., Feb 2014, In : Current oncology reports. 16, 2, 365.

Research output: Contribution to journalArticle

45 Scopus citations

Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase

Satpathy, M., Cao, L., Pincheira, R., Emerson, R., Bigsby, R., Nakshatri, H. & Matei, D., Aug 1 2007, In : Cancer Research. 67, 15, p. 7194-7202 9 p.

Research output: Contribution to journalArticle

79 Scopus citations

ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer

Matulonis, U. A., Lee, J., Lasonde, B., Tew, W. P., Yehwalashet, A., Matei, D., Behbakht, K., Grothusen, J., Fleming, G., Lee, N. K., Arnott, J., Bray, M. R., Fletcher, G., Brokx, R. D., Castonguay, V., MacKay, H., Sidor, C. F. & Oza, A. M., Jan 1 2013, In : European Journal of Cancer. 49, 1, p. 121-131 11 p.

Research output: Contribution to journalArticle

28 Scopus citations

Epigenetic resensitization to platinum in ovarian cancer

Matei, D., Fang, F., Shen, C., Schilder, J., Arnold, A., Zeng, Y., Berry, W. A., Huang, T. & Nephew, K. P., May 1 2012, In : Cancer Research. 72, 9, p. 2197-2205 9 p.

Research output: Contribution to journalArticle

228 Scopus citations

Epigenetic targeting of ovarian cancer stem cells

Wang, Y., Cardenas, H., Fang, F., Condello, S., Taverna, P., Segar, M., Liu, Y., Nephew, K. P. & Matei, D., Sep 1 2014, In : Cancer Research. 74, 17, p. 4922-4936 15 p.

Research output: Contribution to journalArticle

77 Scopus citations

Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase

Shao, M., Cao, L., Shen, C., Satpathy, M., Chelladurai, B., Bigsby, R. M., Nakshatri, H. & Matei, D., Dec 15 2009, In : Cancer Research. 69, 24, p. 9192-9201 10 p.

Research output: Contribution to journalArticle

91 Scopus citations

Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer

Yakubov, B., Chelladurai, B., Schmitt, J., Emerson, R., Turchi, J. J. & Matei, D., Jan 1 2013, In : Neoplasia (United States). 15, 6, p. 609-619 11 p.

Research output: Contribution to journalArticle

35 Scopus citations

EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells

Cardenas, H., Zhao, J., Vieth, E., Nephew, K. P. & Matei, D., Jan 1 2016, In : Oncotarget. 7, 51, p. 84453-84467 15 p.

Research output: Contribution to journalArticle

18 Scopus citations

Gene expression in epithelial ovarian carcinoma

Matei, D., Graeber, T. G., Baldwin, R. L., Karlan, B. Y., Rao, J. & Chang, D. D., Jan 1 2002, In : Oncogene. 21, 41, p. 6289-6298 10 p.

Research output: Contribution to journalArticle

82 Scopus citations

Genomic and epigenomic signatures in ovarian cancer associated with resensitization to platinum drugs

Fang, F., Cardenas, H., Huang, H., Jiang, G., Perkins, S. M., Zhang, C., Keer, H. N., Liu, Y., Nephew, K. P. & Matei, D., Feb 1 2018, In : Cancer Research. 78, 3, p. 631-644 14 p.

Research output: Contribution to journalArticle

21 Scopus citations

Global DNA methylation profiling technologies and the ovarian cancer methylome

Tang, J., Fang, F., Miller, D. F., Pilrose, J. M., Matei, D., Huang, T. H. M. & Nephew, K. P., Jan 1 2015, In : Methods in Molecular Biology. 1238, p. 653-675 23 p.

Research output: Contribution to journalArticle

12 Scopus citations

High-throughput immunomagnetic cell detection using a microaperture chip system

Chang, C. L., Jalal, S. I., Huang, W., Mahmood, A., Matei, D. E. & Savran, C. A., Sep 2014, In : IEEE Sensors Journal. 14, 9, p. 3008-3013 6 p., 6808412.

Research output: Contribution to journalArticle

12 Scopus citations

Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer

Chan, M. W. Y., Wei, S. H., Wen, P., Wang, Z., Matei, D. E., Liu, J. C., Liyanarachchi, S., Brown, R., Nephew, K. P., Yan, P. S. & Huang, T. H. M., Oct 15 2005, In : Clinical Cancer Research. 11, 20, p. 7376-7383 8 p.

Research output: Contribution to journalArticle

54 Scopus citations

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

Zhang, S., Balch, C., Chan, M. W., Lai, H. C., Matei, D., Schilder, J. M., Yan, P. S., Huang, T. H. M. & Nephew, K. P., Jun 1 2008, In : Cancer Research. 68, 11, p. 4311-4320 10 p.

Research output: Contribution to journalArticle

874 Scopus citations

IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells

Wang, Y., Zong, X., Mitra, S., Mitra, A. K., Matei, D. & Nephew, K. P., Dec 6 2018, In : JCI Insight. 3, 23

Research output: Contribution to journalArticle

Open Access
12 Scopus citations
93 Scopus citations

Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: A Hoosier Oncology Group trial

Matei, D., Emerson, R. E., Schilder, J., Menning, N., Baldridge, L. A., Johnson, C. S., Breen, T., McClean, J., Stephens, D., Whalen, C. & Sutton, G., Aug 15 2008, In : Cancer. 113, 4, p. 723-732 10 p.

Research output: Contribution to journalArticle

57 Scopus citations

Intracellular Doppler Signatures of Platinum Sensitivity Captured by Biodynamic Profiling in Ovarian Xenografts

Merrill, D., An, R., Sun, H., Yakubov, B., Matei, D., Turek, J. & Nolte, D., Jan 6 2016, In : Scientific reports. 6, 18821.

Research output: Contribution to journalArticle

7 Scopus citations

Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: Results of a randomized, double-blind, phase 2, parallel-arm study

Tew, W. P., Colombo, N., Ray-Coquard, I., Del Campo, J. M., Oza, A., Pereira, D., Mammoliti, S., Matei, D., Scambia, G., Tonkin, K., Shun, Z., Sternas, L. & Spriggs, D. R., Feb 1 2014, In : Cancer. 120, 3, p. 335-343 9 p.

Research output: Contribution to journalArticle

34 Scopus citations

In vivo tumor growth of high-grade serous ovarian cancer cell lines

Mitra, A. K., Davis, D. A., Tomar, S., Roy, L., Gurler, H., Xie, J., Lantvit, D. D., Cardenas, H., Fang, F., Liu, Y., Loughran, E., Yang, J., Sharon Stack, M., Emerson, R. E., Cowden Dahl, K. D., Barbolina, M. V., Nephew, K. P., Matei, D. & Burdette, J. E., Aug 1 2015, In : Gynecologic oncology. 138, 2, p. 372-377 6 p.

Research output: Contribution to journalArticle

61 Scopus citations

Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells

Li, J., Condello, S., Thomes-Pepin, J., Ma, X., Xia, Y., Hurley, T. D., Matei, D. & Cheng, J. X., Mar 2 2017, In : Cell Stem Cell. 20, 3, p. 303-314.e5

Research output: Contribution to journalArticle

131 Scopus citations

Live tissue viability and chemosensitivity assays using digital holographic motility contrast imaging

An, R., Turek, J., Elena Matei, D. & Nolte, D., Jan 1 2013, In : Applied Optics. 52, 1, p. A300-A309

Research output: Contribution to journalArticle

7 Scopus citations

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy

Friedlander, M., Matulonis, U., Gourley, C., du Bois, A., Vergote, I., Rustin, G., Scott, C., Meier, W., Shapira-Frommer, R., Safra, T., Matei, D., Shirinkin, V., Selle, F., Fielding, A., Lowe, E. S., McMurtry, E. L., Spencer, S., Rowe, P., Mann, H., Parry, D. & 1 others, Ledermann, J., Oct 30 2018, In : British Journal of Cancer. 119, 9, p. 1075-1085 11 p.

Research output: Contribution to journalArticle

28 Scopus citations

Minireview: Epigenetic changes in ovarian cancer

Balch, C., Fang, F., Matei, D., Huang, T. H. M. & Nephew, K., 2009, In : Journal of Clinical Endocrinology and Metabolism. 94, 9, p. 3617 1 p.

Research output: Contribution to journalArticle

MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer

Chan, J. K., Kiet, T. K., Blansit, K., Ramasubbaiah, R., Hilton, J. F., Kapp, D. S. & Matei, D., Jun 2014, In : Gynecologic oncology. 133, 3, p. 568-574 7 p.

Research output: Contribution to journalArticle

43 Scopus citations

NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer

Özeş, A. R., Miller, D. F., Özeş, O. N., Fang, F., Liu, Y., Matei, D., Huang, T. & Nephew, K. P., Oct 13 2016, In : Oncogene. 35, 41, p. 5350-5361 12 p.

Research output: Contribution to journalArticle

111 Scopus citations

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

Moore, K. N., Secord, A. A., Geller, M. A., Miller, D. S., Cloven, N., Fleming, G. F., Wahner Hendrickson, A. E., Azodi, M., DiSilvestro, P., Oza, A. M., Cristea, M., Berek, J. S., Chan, J. K., Rimel, B. J., Matei, D. E., Li, Y., Sun, K., Luptakova, K., Matulonis, U. A. & Monk, B. J., May 2019, In : The lancet oncology. 20, 5, p. 636-648 13 p.

Research output: Contribution to journalArticle

23 Scopus citations